China Medical System Holdings Limited (HKG:0867)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.28
-0.27 (-2.56%)
Jun 30, 2026, 4:08 PM HKT

HKG:0867 Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, HKG:0867 stock has a consensus rating of "Strong Buy" and an average price target of $18.13. The average 1-year stock price forecast is 76.36% higher than the current stock price, while the lowest is $15.40 (+49.81%) and the highest is $19.96 (+94.16%).

Price Target: $18.13 (+76.36%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15.40$18.13$18.13$19.96
Change+49.81%+76.36%+76.36%+94.16%
* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for HKG:0867 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26Jun '26
Strong Buy888767
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total101010989

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$18.63$19.05
BuyMaintains$18.63$19.05+85.31%Apr 29, 2026
Unknown Analyst
First Shanghai Securities
No rating
First Shanghai Securities
Buy
Maintains
$19.30
BuyMaintains$19.30+87.74%Mar 20, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$16.50$17.50
BuyMaintains$16.50$17.50+70.23%Mar 19, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
9.86B
from 8.21B
Increased by 20.03%
Revenue Next Year
11.66B
from 9.86B
Increased by 18.26%
EPS This Year
0.82
from 0.73
Increased by 12.20%
EPS Next Year
1.01
from 0.82
Increased by 22.27%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.34B9.15B8.01B7.47B8.21B9.86B
Revenue Growth
20.03%9.75%-12.43%-6.79%9.95%20.03%
Gross Profit
6.25B7.04B6.08B5.42B5.87B6.99B
Gross Margin
74.93%76.89%75.82%72.60%71.50%70.92%
Operating Income
3.15B3.55B2.71B1.65B1.58B2.19B
Net Income
3.02B3.26B2.40B1.62B1.49B2.01B
EPS
----0.730.82
EPS Growth
----3.94%12.20%
Forward PE
7.977.718.908.7714.8110.82
Dividend / Share
0.490.530.390.270.290.37
Dividend Growth
-8.84%-26.70%-31.55%8.95%26.18%
Free Cash Flow
1.35B2.09B1.55B544.94M212.65M1.46B
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High10.0B
Avg9.9B
Low9.7B

Revenue Growth

Revenue Growth202620272028
High
22.1%
Avg
20.0%
Low
17.8%

EPS Forecast

EPS202620272028
High0.87
Avg0.82
Low0.80

EPS Growth

EPS Growth202620272028
High
18.6%
Avg
12.2%
Low
9.0%